-
1Academic Journal
Συγγραφείς: V. A. Beloborodov, I. A. Stepanov, E. A. Kelchevskaya, V. A. Vorobiev, A. P. Frolov, M. A. Kozhevnikov, A. R. Tukhiev, V. E. Borisov, Z. S. Saakyan, В. А. Белобородов, И. А. Степанов, Е. А. Кельчевская, В. А. Воробьев, А. П. Фролов, М. А. Кожевников, А. Р. Тухиев, В. Э. Борисов, З. С. Саакян
Πηγή: Acta Biomedica Scientifica; Том 9, № 5 (2024); 168-177 ; 2587-9596 ; 2541-9420
Θεματικοί όροι: поражение периферической нервной системы, SARS-CoV-2, central nervous system, clinical and neurological manifestations, pathogenesis, stroke, peripheral neuropathy, центральная нервная система, клинико-неврологические проявления, патогенез, инсульт
Περιγραφή αρχείου: application/pdf
Relation: https://www.actabiomedica.ru/jour/article/view/5046/2912; Арутюнов Г.П., Козиолова Н.А., Тарловская Е.И., Арутюнов А.Г., Григорьева Н.Ю., Джунусбекова Г.А., и др. Согласованная позиция экспертов Евразийской ассоциации терапевтов по некоторым новым механизмам патогенеза COVID-19: фокус на гемостаз, вопросы гемотрансфузии и систему транспорта газов крови. Кардиология. 2020; 60(5): 9-19.; Колобухина Л.В., Бургасова О.А., Краева Л.А., Гущин В.А., Бурцева Е.И., Кружкова И.С., и др. Клинико-лабораторный профиль пациентов с COVID-19, госпитализированных в инфекционный стационар г. Москвы в период с мая по июль 2020 года. Инфекционные болезни. 2021; 19(2): 5-15.; Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Scie. 2020; 413: 116832. doi:10.1016/j.jns.2020.116832; Satarker S, Nampoothiri M. Involvement of the nervous system in COVID-19: The bell should toll in the brain. Life Scie. 2020; 262: 118568. doi:10.1016/j.lfs.2020.118568; Bobker SM, Robbins MS. COVID-19 and headache: A primer for trainees. Headache. 2020; 60(8): 1806-1811. doi:10.1111/head.13884; Walls AC, Fiala B, Schäfer A, Wrenn S, Pham MN, Murphy M, et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell. 2020; 183(5): 1367-1382.e17. doi:10.1016/j.cell.2020.10.043; Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 102433. doi:10.1016/j.jaut.2020.102433; Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020; 94(7): e00127-20. doi:10.1128/JVI.00127-20; Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007; 292(1): R373-R381. doi:10.1152/ajpregu.00292.2006; Palasca O, Santos A, Stolte C, Gorodkin J, Jensen LJ. TISSUES 2.0: An integrative web resource on mammalian tissue expression. Database (Oxford). 2018; 2018: bay028. doi:10.1093/database/bay028; McCray PB Jr, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007; 81(2): 813-821. doi:10.1128/JVI.02012-06; Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020; 194: 105921. doi:10.1016/j.clineuro.2020.105921; Divani AA, Andalib S, Biller J, Di Napoli M, Moghimi N, Rubinos CA, et al. Central nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2020; 20(12): 60. doi:10.1007/s11910-020-01079-7; Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020; 11(7): 995-998. doi:10.1021/acschemneuro.0c00122; Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6): 552-555. doi:10.1002/jmv.25728; Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683-690. doi:10.1001/jamaneurol.2020.1127; Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi:10.1016/S0140-6736(20)30183-5; Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395(10223): 507-513. doi:10.1016/S0140-6736(20)30211-7; Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ. 2020; 368: m606. doi:10.1136/bmj.m606; Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-1069. doi:10.1001/jama.2020.1585; Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020; 80(4): 401-406. doi:10.1016/j.jinf.2020.02.018; Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-1720. doi:10.1056/NEJMoa2002032; Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020; 95(8): e1060-e1070. doi:10.1212/WNL.0000000000009937; Belvis R. Headaches during COVID-19: My clinical case and review of the literature. Headache. 2020: 60(7): 1422-1426. doi:10.1111/head.13841; Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4): e21. doi:10.1016/S2213-2600(20)30116-8; Maassen Van Den Brink A, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic. J Headache Pain. 2020; 21(1): 38. doi:10.1186/s10194-020-01106-5; Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I. Ibuprofen use and clinical outcomes in COVID-19 patients. Clin Microbiol Infect. 2020; 26(9): 1259.e5-1259.e7. doi:10.1016/j.cmi.2020.06.003; Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020; 368: m1091. doi:10.1136/bmj.m1091; Alkeridy WA, Almaghlouth I, Alrashed R, Alayed K, Binkhamis K, Alsharidi A, et al. A unique presentation of delirium in a patient with otherwise asymptomatic COVID-19. J Am Geriatr Soc. 2020; 68(7): 1382-1384. doi:10.1111/jgs.16536; Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020; 382: 2268-2270. doi: 10. 1056/NEJMc2008597; Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020; 24(1): 176. doi:10.1186/s13054-020-02882-x; Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T, et al. COVID-19 and the chemical senses: Supporting players take center stage. Neuron. 2020; 107(2): 219-233. doi:10.1016/j.neuron.2020.06.032; Galougahi MK, Ghorbani J, Bakhshayeshkaram M, Naeini AS, Haseli S. Olfactory bulb magnetic resonance imaging in SARS- CoV-2-induced anosmia: The first report. Acad Radiol. 2020; 27(6): 892-893. doi:10.1016/j.acra.2020.04.002; Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, et al. More than smell – COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020; 45(7): 609-622. doi:10.1093/chemse/bjaa041; Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC 3rd. COVID-19 anosmia reporting tool: Initial findings. Otolaryngol Head Neck Surg. 2020; 163(1): 132-134. doi:10.1177/0194599820922992; Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in SARSCoV-2 patients: A cross-sectional study. Clin Infect Dis. 2020; 71(15): 889-890. doi:10.1093/cid/ciaa330; Menni C, Valdes A, Freydin MB, Ganesh S, El-Sayed Moustafa J, Visconti A, et al. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. medRxiv. 2020; 2020.04.05.20048421. doi:10.1101/2020.04.05.20048421; Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8): 2251-2261. doi: 10. 1007/s00405-020-05965-1; Song J, Deng Y-K, Wang H, Wang Z-C, Liao B, Ma J, et al. Self-reported taste and smell disorders in patients with COVID-19: Distinct features in China. medRxiv. 2020: 41(1): 14-23. doi:10.1007/s11596-021-2312-7; Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020; 87: 115-119. doi:10.1016/j.bbi.2020.04.077; Karimi N, Sharifi Razavi A, Rouhani N. Frequent convulsive seizures in an adult patient with COVID-19: A case report. Iran Red Crescent Med J. 2020; 22(3): e102828. doi:10.5812/ircmj.102828; Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 55-58. doi:10.1016/j.ijid.2020.03.062; Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia. 2020; 61(6): 49-53. doi:10.1111/epi.16524; Yazbeck M, Sra P, Parvizi J. Rapid response electroencephalography for urgent evaluation of patients in community hospital intensive care practice. J Neurosci Nurs. 2019; 51(6): 308-312. doi:10.1097/jnn.0000000000000476; Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute symptomatic seizures in critically ill patients with COVID-19: Is there an association? Neurocrit Care. 2021; 34(1): 139-143. doi:10.1007/s12028-020-01006-1; Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal status epilepticus as unique clinical feature of COVID-19: A case report. Seizure. 2020; 78: 109-112. doi:10.1016/j.seizure.2020.04.009; Louis S, Dhawan A, Newey C, Nair D, Jehi L, Hantus S, et al. Continuous electroencephalography (cEEG) characteristics and acute symptomatic seizures in COVID-19 patients. medRxiv. 2020; 131(11): 2651-2656. doi:10.1101/2020.05. 26.20114033; Galanopoulou AS, Ferastraoaru V, Correa DJ, Cherian K, Duberstein S, Gursky J, et al. EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report. Epilepsia Open. 2020; 5(2): 314-324. doi:10.1002/epi4.12399; Morfopoulou S, Brown JR, Davies EG, Anderson G, Virasami A, Qasim W, et al. Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med. 2016; 375(5): 497-498. doi:10.1056/NEJMc1509458; Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020; 201187: 119-120. doi:10.1148/radiol.2020201187; Щербак С.Г., Вологжанин Д.А., Камилова Т.А., Голота А.С. Острые нарушения мозгового кровообращения при COVID-19. Университетский терапевтический вестник. 2023; 5(1): 5-35.; Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, Rodríguez-Gutiérrez R. Acute cerebrovascular events in severe and nonsevere COVID-19 patients: A systematic review and meta-analysis. Rev Neurosci. 2022; 33(6): 631-639. doi:10.1515/revneuro-2021-0130; Чухловина М.Л. Полинейропатии в условиях пандемии COVID-19. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121(5): 138-143.; Leonhard SE. Diagnosis and management of Guillain – Barré syndrome in ten steps. Nat Rev Neurol. 2019; 15(11): 671-683. doi:10.1038/s41582-019-0250-9; https://www.actabiomedica.ru/jour/article/view/5046